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Distinct Roles for Arp2/3 Regulators
in Actin Assembly and Endocytosis
Brian J. Galletta, Dennis Y. Chuang, John A. Cooper
*
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
The Arp2/3 complex is essential for actin assembly and motility in many cell processes, and a large number of proteins
have been found to bind and regulate it in vitro. A critical challenge is to understand the actions of these proteins in
cells, especially in settings where multiple regulators are present. In a systematic study of the sequential
multicomponent actin assembly processes that accompany endocytosis in yeast, we examined and compared the
roles of WASp, two type-I myosins, and two other Arp2/3 activators, along with that of coronin, which is a proposed
inhibitor of Arp2/3. Quantitative analysis of high-speed fluorescence imaging revealed individual functions for the
regulators, manifested in part by novel phenotypes. We conclude that Arp2/3 regulators have distinct and overlapping
roles in the processes of actin assembly that drive endocytosis in yeast. The formation of the endocytic actin patch, the
creation of the endocytic vesicle, and the movement of the vesicle into the cytoplasm display distinct dependencies on
different Arp2/3 regulators. Knowledge of these roles provides insight into the in vivo relevance of the dendritic
nucleation model for actin assembly.
Citation: Galletta BJ, Chuang DY, Cooper JA (2008) Distinct roles for Arp2/3 regulators in actin assembly and endocytosis. PLoS Biol 6(1): e1. doi:10.1371/journal.pbio.0060001
Introduction
Dynamic networks of branched actin ﬁlaments are fre-
quently found adjacent to membranes and appear to play a
role in many cellular process (reviewed in [1]). The dendritic
nucleation model provides a framework to understand how
networks of branched actin ﬁlaments assemble and generate a
pushing force [2–4]. A key step in the formation of a
branched actin ﬁlament network is the activation of the
Arp2/3 complex, which nucleates a new actin ﬁlament from
the side of an existing ﬁlament. This new growing ﬁlament
pushes against the membrane. Arp2/3 normally exists in an
inactive state and requires an activator protein to induce a
large conformational change, which allows for nucleation of a
new actin ﬁlament (reviewed in [1,5,6]). Coronin, an Arp2/3
inhibitor, stabilizes Arp2/3 in the inactive conformation [7].
In some cases, targeting the Arp2/3 complex to a
subcellular location—rather than activating it—may be the
principal role for an Arp2/3-binding protein (reviewed in
[3,8–10]). Of note, with yeast actin as a substrate, the yeast
Arp2/3 complex nucleated polymerization rather well in the
absence of an activator [8,11]. Activators enhanced the
activity of the Arp2/3 complex in these studies, but by a
relatively small amount. Thus, yeast Arp2/3 activators may be
critical for spatial control of actin assembly by targeting,
rather than activating, Arp2/3.
An important challenge for the ﬁeld is to understand how
the activities of multiple Arp2/3-activating proteins are
coordinated in vivo. Do these activators have overlapping
functions or does each of these proteins have a unique role in
the formation of a proper network? We addressed this
question by investigating the roles of all of the proposed
Arp2/3 regulatory proteins in the assembly and movement of
cortical actin patches in Saccharomyces cerevisiae. Actin patches
contain ﬁve proteins with an acidic/DDW motif for binding
the Arp2/3 complex: a WASp (Las17); two type-I myosins
(Myo3 and Myo5); an Eps15 homology (EH) protein (Pan1);
and an actin ﬁlament–binding protein (Abp1) (Figure 1A)
[12]. The acidic/DDW region is necessary and sufﬁcient to
bind the Arp2/3 complex, and all of these proteins can bind
and activate Arp2/3 in vitro [13–20]. Actin patches also
contain a coronin, Crn1, which can inhibit Arp2/3 activation
in vitro [21,22]. The actin patch provides an excellent system
to test the roles of these regulators in a single, complex,
multicomponent system.
In yeast, actin patch assembly and movement mediates
endocytosis [23–27]. Actin patches assemble at the plasma
membrane as the endocytic vesicle forms. Patches then move
into the cell with the vesicle [24,28,29]. Patch formation and
movement occurs rapidly, on a time scale of seconds to
minutes, and depends on Arp2/3 complex and actin polymer-
ization [29–32].
The life cycle of an actin patch is a stereotyped sequence of
events that is characterized by changes in protein composi-
tion, location, and movement; this can be seen as three phases
(Figure 1B). In phase I, actin patches assemble at the cortex
and display a limited amount of motion, as if tethered in
place. Many proteins are recruited to the actin patch during
this phase, including WASp/Las17 and endocytic adaptors
Sla1, Sla2, and Pan1. Near the end of phase I, the actin
ﬁlament network begins to assemble, as indicated by the
arrival of the Arp2/3 complex, capping protein (Cap1/Cap2;
CP), and the actin ﬁlament–binding proteins ﬁmbrin/Sac6
and Abp1 [24,33]. Phase II is characterized by slow movement
of the patch a short distance into the cell, away from the
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plasma membrane. Some patch components appear to
remain at the membrane during this movement, such as
Las17 and Myo5 [24,34], whereas others appear to move into
the cell, including Sla1, Sla2, Pan1, Arp2/3, CP, and Abp1. At
the end of phase II, several proteins are lost from the patch,
including Sla1, Sla2, and Pan1. During phase III, patches
contain actin ﬁlaments and actin-binding proteins, and they
undergo more rapid and lengthy movement into the cell
before disappearing [24,33].
In this study, we used high-speed video microscopy,
coupled with computer-assisted patch tracking and quanti-
tative motion analysis, to study the effect of mutations in
genes for Arp2/3 regulators on the assembly and movement of
actin patches marked by green ﬂuorescent protein (GFP)-
labeled components. The methodology allowed the study of
large numbers of patches, which revealed novel phenotypes in
the mutants. These studies provide new evidence about the
function of each of the Arp2/3 regulatory proteins and reveal
that these regulators have some roles that are distinct from
each other, as well as some that are overlapping.
Results
The Acidic/DDW Domain of WASp/Las17 Is Important for
Actin Patch Motility
Las17, the yeast WASp protein, binds to and activates Arp2/
3 via an acidic/DDW region at its C terminus (Figure 1A)
[11,19]. To determine the role that this region plays in actin
patch motility, a C-terminal truncation that removed the
acidic/DDW region was generated. All of the mutations
described in this study were made at the endogenous locus
and were examined in haploids, where the mutant allele was
the only allele of the gene present. The mutation removed the
Arp2/3-binding region but not other known domains,
including the WH2 domain that binds actin monomer. The
truncated Las17 localized to actin patches by GFP tagging
(data not shown).
We tracked the positions of hundreds of patches over time
and then used several forms of quantitative motion analysis
to assess the effect of mutations. The methodology is
described fully in Materials and Methods. Mean squared
displacement (MSD) plots were one form of analysis, and
examples of how such plots were generated and used to
monitor each phase of the patch life cycle are presented in
Figure 1C–1E. We ﬁrst examined the effects of this mutation
on phase I and II of patch motility using Sla2-GFP labeling
(Video S1). MSD plots, generated from displacement data of
individual patches aligned at the start of their lifetimes and
then averaged, indicated a defect in the behavior of
las17Dacidic patches during phase I or II. In contrast, MSD
plots of the same data, averaged after aligning individual
patch curves at the end of their lifetimes, showed no defect in
the mutant (Figure 2A).
To examine phases I and II more closely, we quantitated
directly the frequency and timing of early events. The amount
of time that patches spent at their origin, before moving off
the membrane, was greatly increased in las17Dacidic mutant
cells (Figure 2C), which can account for the observed defect in
MSD plots aligned at the start (Figure 2A). The percentage of
patches that left the membrane, corresponding to transition
from phase I to phase II, was essentially normal (Figure 2B).
To determine if the timing of the recruitment of actin was
normal in las17Dacidic cells, we determined the time between
the appearance of Sla2 and of Abp1, a marker of actin
ﬁlaments. The arrival of actin ﬁlaments to the patch was
delayed in las17Dacidic cells (Figure S1). To examine patch
movement during phase II, we isolated tracking data for
patches—after they moved off the membrane—with Sla2-GFP
labeling. In this analysis, the las17Dacidic cells were normal
(Figure 2D). Taken together, the data support a model where
the acidic domain of Las17 is critical for the duration of
phase I but not for the ability of the patch to leave the
membrane or for its initial movement off the membrane.
The effect of the las17Dacidic mutation on the movement of
actin patches during phase III was examined using Abp1-GFP
(Video S2). Patch movement was decreased in the mutant and
was assessed with MSD plots aligned at the start or the end of
patch lifetime (Figure 2E). Decreased movement at the start
of Abp1-GFP patch life can result from a prolongation of
phase I, as seen with Sla2-GFP. Indeed, as expected, the time
that Abp1-GFP patches remained at their origin was
prolonged (Figure 2G), and the percentage of patches that
moved away from their origin was slightly reduced in
las17Dacidic cells (Figure 2F).
MSD plots aligned at the end of patch lifetimes showed a
decrease in movement, as noted above (Figure 2E, right). We
tested the phase III movement directly by isolating tracking
data for patches after they moved 200 nm from their
membrane origin. Patches of las17Dacidic cells showed
decreased movement in MSD plots aligned at the beginning
and end of this movement (Figure 2H).
In previous studies in yeast, GFP-labeled WASp proteins
remained on the membrane, exhibiting phase I behavior, and
did not move off the membrane [24,33,35] These results
raised the question of how the Arp2/3 complex and actin
assembly might power the movement of endocytic vesicles
into and about the cytoplasm. We found similar results with
PLoS Biology | www.plosbiology.org January 2008 | Volume 6 | Issue 1 | e10073
Arp2/3 Regulators
Author Summary
A branched network of growing actin filaments, pushing against a
membrane, provides the force for certain cellular movements. The
Arp2/3 complex plays a central role in this process by generating
new filaments and branch points. A number of proteins bind to and,
in some cases, regulate Arp2/3. It is important to determine, in the
cell, the precise roles of each of the many Arp2/3 regulators in
generating actin networks during a complex, multistep, cellular
movement. In yeast, endocytosis occurs at the plasma membrane in
association with the assembly and movement of cortical actin
patches, which contain six Arp2/3 regulators. We have used the
actin patch as a model system to determine the specific roles of
these regulators during patch assembly and movement. We used
high-speed video microscopy, coupled with computer-aided particle
tracking, to monitor the movement of fluorescently labeled actin
patches in cells with one or more mutations of the Arp2/3
regulators. The sensitivity of this technique allowed us to identify
previously unappreciated functions for Arp2/3 regulators and to
assign each of the regulators a specific role during actin patch
assembly and movement. Our results demonstrate that Arp2/3
regulatory proteins play overlapping roles at certain stages of actin
patch movement, but distinct roles at other stages. In addition, our
results provide new insight into how the assembly of an actin
filament networks powers the movement of endocytic vesicles away
from the membrane.
GFP fused to the C terminus of Las17. However, we ﬁnd that
neither C- nor N-terminal fusions of GFP to Las17, which
were expressed from the endogenous las17 locus, are fully
functional for actin patch motility, especially for the late
movements of phase III (Figures S2 and S3). Interestingly,
when we overexpressed a novel N-terminal fusion from the
GAL1 promoter, approximately one-third of GFP-Las17–
labeled patches exhibited substantial movement away from
their origin. They moved into and about the cytoplasm, as
seen in confocal movies taken at the equator of the cell
(Figure 2I–2J, Videos S3–S4). Although this method is
technically challenging, we have observed examples of
colocalization of these particles moving into the cytoplasm
with Abp1-tdimer2 (Video S5). However, this GFP fusion
protein may also not reveal the normal localization of the
Las17 protein. Actin patch motility in strains expressing this
fusion was impaired, especially during phase III (Figure S4),
indicating that Las17 function was not normal in these
strains. In addition, cells expressing GFP-Las17 from the
GAL1 promoter have a distinct population of GFP-Las17
particles moving freely inside the cell (Figure 2K, Video S6).
These particles have a markedly greater lifetime than do actin
patches, so the particles may correspond to membranous
vesicles moving in the cytoplasm reported in previous studies
[33,36,37].
Type-I Myosins Have Distinct but Overlapping Functions
The C termini of fungal type-I myosins, including Myo3
and Myo5 of budding yeast, have an acidic/DDW sequence
that binds Arp2/3 complex (Figure 1A) [14,17,38,39]. These
type-I myosins are capable of activating Arp2/3 in vitro when
they are artiﬁcially connected to a WH2 domain or in the
presence of the WH2-containing protein, Vrp1, the yeast
WASp-interacting protein (WIP) [13,15]. To determine the
role of type-I myosins in actin patch motility, we examined
the effect of the deletion of the myo3 and myo5 genes on Abp1-
GFP dynamics. myo3D cells were normal, by MSD analysis
(Figure 3E), with no defects in the percentage of patches
leaving the origin or the time that patches spent at the origin
(Figure 3F–3G). In contrast, myo5D cells had substantial
defects in Abp1-GFP motility (Figure 3E). The median
lifetime of Abp1-GFP patches in the absence of Myo5 was
found to be increased, and the distance of the movement of
Abp1-GFP patches was decreased, in MSD plots with patch
tracks aligned at the beginning and at the end of their
lifetimes. The time that Abp1-GFP patches spent at the origin
was increased in myo5D cells, and the percentage that moved
away from the origin was decreased (Figure 3F–3G).
The effect of the loss of Myo5 on the early phases of actin
patch motility was also examined using Sla2-GFP labeling.
MSD plots of Sla2-GFP movement, aligned at the beginning
and at the end of patch lifetimes, revealed decreased
movement with an increase in median lifetime (Figure 3A).
?>
Figure 1. Acidic Domains of Arp2/3 Activators, Model of Actin Patch
Assembly and MSD Examples
(A) Alignment of acidic/DDW regions of S. cerevisiae Arp2/3 activators
with the corresponding regions of human WASp and N-WASp. Acidic
residues are highlighted with gray and the conserved tryptophan with
black. Numbers are amino acid residues. The entire region shown here
was removed in ‘‘Dacidic’’ strains.
(B) Model of actin patch formation and movement, adapted from
previous studies [23,24,33], are shown.
(C) Examples of squared displacement plotted versus time for five
individual patches, with the curves aligned at the start (left) or (right) end
of patch lifetime. Such curves would then be averaged to generate MSD
plots.
(D) Typical MSD plots of wild-type patches labeled with Sla2-GFP
generated by aligning individual curves at the start (left) or the end
(right) of patch lifetime. On the left, the plot is truncated when half of the
patches have disappeared, indicating the median lifetime. Phases I and II
of patch movement are indicated.
(E) Typical MSD plots of wild-type patches labeled with Abp1-GFP
generated as in (D). Phase III patch movements are indicated.
doi:10.1371/journal.pbio.0060001.g001
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Figure 2. Quantitative Motion Analysis of las17Dacidic Patches and the Movement of GFP-WASp/Las17 Particles
Cells express Sla2-GFP (A–D), Abp1-GFP (E–H), or GFP-Las17 (I–K).
(A) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the
median lifetime.
(B) Percentage of patches that leave the origin. Mean of values for three segregants is shown.
(C) Average time at the origin, from the appearance of a patch until it moved away or disappeared.
(D) Phase II movement only. For each patch, data prior to movement were removed.
(E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median
lifetime.
(F) Percentage of patches that leave the origin, as in (B).
(G) Average time at the origin, as in (C).
(H) Phase III movement only. For each patch, data prior to the time the patch traveled 200 nm were removed. Only patches that moved at least 200 nm
are included.
(I–K) Time-lapse fluorescence images at the indicated intervals. Arrowheads indicate the position of the particle at time zero, and arrows follow the
position of the particle over time. (I and J) Particles, presumably actin patches, appear at the cortex and move away. (K) A GFP-WASp/Las17 particle
moving inside the cell. The path taken by the particle from time zero is overlaid in green. Scale bars, 500 nm.
Strain numbers and the number of patches were as follows: (A–C) Wild-type, YJC5234–6; 106, 93, and 108, respectively. las17Dacidic, YJC5231–3; 100,
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This defect was due in part to a decrease in the frequency
with which Sla2-GFP patches left the origin and an increase
in the time the patches spent at the membrane (Figure 3B–
3C). To determine if the phase II movement of patches in
myo5D cells was normal when they did leave the membrane,
we isolated and analyzed movement of Sla2-GFP–labeled
patches from the membrane. Phase II patch movement was
found to be decreased in the myo5D cells by MSD analysis
(Figure 3D).
Observations of cell growth and endocytosis have indicated
that Myo3 and Myo5 have overlapping functions, with
apparent redundancy in some cases [40,41]. To address this
question, we examined Abp1-GFP patch behavior in myo3D
myo5D double mutants. MSD curves showed a severe defect in
patch motility, with a nearly complete loss of movement away
from the origin and an increase in median patch lifetime,
when compared to wild-type or single-mutant cells (Figure
3E). The percentage of Abp1-GFP patches leaving the
membrane was very small, and the lifetime of patches at the
origin was greatly increased (Figure 3F–3G). The number of
patches leaving the membrane was not sufﬁcient to permit a
direct analysis of phase III movement. Taken together, these
results show that although the function of Myo5 is distinct
from that of Myo3, the proteins do have some functions in
common. The results are consistent with the previous
observation of endocytosis defects in myo5D but not myo3D
single mutants, and with multiple observations that myo5D
myo3D double mutants are more severely affected in growth
and endocytosis than either single mutant alone [40,41].
Arp2/3-Binding Regions of Type-I Myosin and WASp
To determine if the actin patch phenotypes of the type-I
myosin null mutants, myo3D and myo5D, result from loss of
Arp2/3 interaction, we truncated the acidic/DDW region of
each type-I myosin. For Myo5, loss of the acidic/DDW region
had no effect on phase I and II movement except for a small,
statistically signiﬁcant increase in movement in MSD plots of
Sla2-GFP patch tracks aligned at the end of their lifetime
(Figure 3H–3J). For phase III movement, which was assessed
with Abp1-GFP, MSD curves showed a slight leftward shift
when tracks were aligned at the start, but no change when
aligned at the end (Figure 3K). Abp1-GFP patches remained
at the origin for slightly less time in the mutant cells (Figure
3M; p¼ 0.0003), but the frequency with which patches moved
away from the origin was normal (Figure 3L). These results
were a surprising contrast to those for the myo5D null mutant,
which had a strong defect in phase III and signiﬁcant ones in
phases I and II. For Myo3, a similar truncation of the acidic/
DDW region had no effect on phase I or II of actin patch
movement, which were examined with Sla2-GFP (Figure 3H–
3J), or on phase III, which was examined using Abp1-GFP
(Figure 3K–3M). These results were largely similar those for
the myo3D null mutant and thus not surprising.
To determine if the absence of a phenotype in the single-
mutant strains was a result of functional redundancy, we
examined cells carrying both truncation mutations. Patch
movement was again remarkably unaffected. The double
mutant produced results very similar to those for the Myo5
single mutant for all three phases of patch life (Figure 3H–3J).
During phase III, actin patches of double-mutant cells were
slightly different from those of the Myo5 single mutant
(Figure 3K–3M), but this difference barely achieved statistical
signiﬁcance.
Overall, the Arp2/3-binding regions of Myo3 and Myo5
were dispensable for function in this otherwise wild-type
genetic background, in striking contrast to the effect of the
complete loss of one or both proteins. Several lines of
evidence suggest that the type-I myosins might function as a
complex with WASp/Las17 and WIP/Vrp1, with overlapping
function among the three Arp2/3-binding regions [14,17,42].
To test this possibility, we examined actin patch motility in
haploid strains carrying a las17Dacidic mutation in combina-
tion with myo3Dacidic and/or myo5Dacidic mutations.
First, we examined phases I and II with Sla2-GFP labeling.
Patch movement in las17Dacidic myo3Dacidic cells was similar
to that in las17Dacidic cells during phases I and II (Figure 3N).
Only small differences of marginal statistical signiﬁcance
were observed for the time that patches remained at the
origin and for the frequency with which patches left the
membrane (Figure 3P and 3O). In contrast, cells lacking the
acidic/DDW regions of WASp/Las17 and Myo5 showed
substantially greater defects than cells lacking only the
acidic/DDW region of WASp/Las17. Patch movement in the
double mutant was decreased, by MSD analysis, compared
with that in the single mutant (Figure 3N). This defect
resulted in large part from a decrease in the frequency with
which patches left the origin to begin phase II movement
(Figure 3O). In addition, patches in las17Dacidic myo5Dacidic
cells spent more time at their point of origin before
disappearing or moving away than did those of las17Dacidic
cells (Figure 3P).
In triple-mutant cells, which lack the acidic domains of
WASp/Las17, Myo3, and Myo5, Sla2-GFP patch motility was
decreased compared with double mutants (Figure 3N). The
frequency with which triple-mutant patches left the origin
was only slightly lower (Figure 3O), and the time that patches
remained at the origin was similar (Figure 3P) when
compared with las17Dacidic myo5Dacidic cells.
Phase III patch movement was examined in these mutants
using Abp1-GFP. The loss of the acidic domain of Myo3 had
little effect on the motility of Abp1-GFP patches in
las17Dacidic cells by MSD analysis (Figure 3Q). The frequency
with which patches moved away from the origin and the time
patches spent at the membrane were very similar (Figure 3R
and 3S), similar to the results with Sla2-GFP labeling. If
anything, loss of the acidic domain of Myo3 suppressed the
phenotype of increased time that Abp1-GFP patches spent at
the membrane in las17Dacidic cells (Figure 3S, p ¼ 0.0007).
In contrast, las17Dacidic myo5Dacidic double-mutant cells had
greater defects in Abp1-GFP patch motility than did las17Daci-
dic cells (Figure 3Q). The percentage of patches that moved
away from their origin was decreased (Figure 3R; p¼0.04), and
the time that patches spent at the membrane prior to moving
away was increased (Figure 3S; p ¼ 0.0004). Patches in
las17Dacidic myo5Dacidic cells still retained a measurable level
83, and 73. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 74, 90. las17Dacidic – 66, 67, 53. (E–G) Wild-type, YJC5214–6; 85, 86, and 98
respectively. las17Dacidic, YJC5208–10; 95, 76, and 89. (H) Strains as in (E–G). Numbers of patches: wild-type – 76, 69, and 84; las17Dacidic – 45, 43, and
49. Error bars are 6 standard error. (I–J) YJC5736–7.
doi:10.1371/journal.pbio.0060001.g002
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of dynamics andmovement, so we asked if Myo3 was important
in this context. Indeed, Abp1-GFP patch motility was
decreased in las17Dacidic myo3Dacidic myo5Dacidic triple-mutant
cells compared to las17Dacidic myo5Dacidic cells, with a nearly
complete loss of motility (Figure 3Q). The percentage of
patches that moved away from the origin was less, and the time
that patches remained at the origin was greater (Figure 3R–3S).
Together, the results indicate that the Arp2/3-binding
regions of WASp and the type-I myosins do have a signiﬁcant
level of functional redundancy, consistent with the notion
that they may act in a complex in which any and all of the
three Arp2/3 complex interactions can be important. In
previous studies suggesting the existence of such a complex,
WIP, known as verprolin/Vrp1 in yeast, was also found in
biochemical association. We found that a WIP null mutant,
vrp1D, had essentially no patch movement, with Sla2-GFP or
Abp1-GFP labeling (unpublished data), in agreement with
another study [15]. Actin patches did still form in all of these
mutants, including the WIP null mutant and the WASp/type-I
myosin triple mutant, showing that actin ﬁlaments can still
polymerize but not with the dynamic control needed to
achieve movement.
A Role for Pan1 in the Early Phases of Patch Assembly
The endocytic adaptor protein Pan1 has an acidic/DDW
region for binding the Arp2/3 complex, along with two EH
domains, a coiled-coil region, and a WH2 domain [43]. Pan1 is
essential for viability in yeast, and because the loss of
endocytosis does not appear to be lethal, this suggests that
Pan1 may have other functions. To investigate the possible
importance of Pan19s interaction with the Arp2/3 complex in
actin patch dynamics, the acidic/DDW region of the Pan1
protein was removed (Figure 1A). The PAN1 gene was
mutated at its endogenous locus in a diploid strain and
tetrad dissection produced haploid mutant segregants that
grew well (Protocol S1). In haploid mutant pan1Dacidic cells
labeled with Sla2-GFP, the time that patches remained at
their origin was slightly increased (Figure 4C), and MSD plots
of tracks aligned at the start of their lifetimes showed
decreased movement (Figure 4A). The percentage of patches
leaving the origin was normal (Figure 4B), as was MSD
analysis with curves aligned at the end of their lifetimes
(Figure 4A). Examining only the data for movement away
from the membrane in phase II, we found that patch
movement was also normal in the mutant (unpublished data).
Thus, only the earliest stages of patch dynamics were affected
by removing the Arp2/3 binding region of Pan1.
WASp / Las17 was also important in the early stages of the
actin patch life cycle, as described above, so we combined the
pan1Dacidic and las17Dacidic mutations. Double-mutant hap-
loid cells had a more severe defect than did either single
mutant, in terms of the time that patches spent at their origin
(Figure 4C) and MSD analysis with curves aligned at the start
(Figure 4A, left). The percentage of patches leaving the origin
was decreased slightly (Figure 4B), and MSD analysis with
curves aligned at the right was normal, similar to the single
mutants (Figure 4A, right). This enhanced phenotype in the
double mutant is consistent with synthetic interactions
between pan1 and las17mutations in terms of cell growth [42].
With Abp1-GFP labeling to examine phase III behavior,
pan1Dacidic single-mutant cells displayed a defect in MSD
plots aligned at the left, no defect in MSD plots aligned at the
right (Figure 4D), a decrease in the percentage of patches that
moved away from the origin (Figure 4E), and a slight increase
in the time that patches remained at the origin before moving
away or disappearing (Figure 4F; p¼0.0005). These results are
consistent with the phase I and II results for this mutant,
based on the Sla2-GFP labeling result above, and they
indicate that phase III patch behavior was normal in the
pan1Dacidic single mutant. For double-mutant las17Dacidic
pan1Dacidic cells labeled with Abp1-GFP, the early phases of
actin patch dynamics were similar to those of las17Dacidic
cells, based on the early time points in MSD plots aligned at
the left. The time that patches spent at the membrane and in
the percentage of patches that moved away from the origin
was also similar (Figure 4E and 4F). However, double-mutant
cells showed an increase in phase III movement, compared to
las17Dacidic cells, at later time points in MSD plots, aligned at
the start or end of patch life (Figure 4D). This rescue is the
result of a combination of an increase in the percentage of
patches making movements beyond 200 nm and an increase
Figure 3. Quantitative Motion Analysis of Actin Patches in Type-I Myosin Mutants
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5D patches
aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave
the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or
disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches
aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage
of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C).
(H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3Dacidic and myo5Dacidic. The panels are similar to those
above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end
(right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values
for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared.
(N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots
for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O
and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the
appearance of a patch until it moved away or disappeared.
Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5D, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers
of patches: wild-type – 88, 69, 85. myo5D – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3D, YJC4409–11; 111, 115, and 105. myo5D,
YJC4813–4; 120 and 99. myo3D myo5D, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3Dacidic, YJC5563–5; 71, 75, and
101. myo5Dacidic, YJC5554–6; 86, 71, and 62. myo3Dacidic myo5Dacidic, YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87.
myo3Dacidic, YJC4843–5; 119, 99, and 106. myo5Dacidic, YJC4840–2; 102, 111, and 99. myo3Dacidic myo5Dacidic, YJC4837–9; 96, 93, and 100. (N–P)
Wild-type, YJC5566–8; 71, 107, and 83. las17Dacidic, YJC5551–3; 84, 64, and 69. las17Dacidic myo3Dacidic, YJC5560–2; 89, 71, and 68. las17Dacidic
myo5Dacidic, YJC5548–50; 51, 66, and 57. las17Dacidic myo3Dacidic myo5Dacidic, YJC5545–7; 43, 53, and 54. (Q–S) las17Dacidic, YJC5208–10; 95, 76, and
89. las17Dacidic myo3Dacidic, YJC5438–40; 111, 104, and 109. las17Dacidic myo5Dacidic, YJC5441–3; 98, 80, and 84. las17Dacidic myo3Dacidic
myo5Dacidic, YJC5205–7; 71, 79, and 99.
doi:10.1371/journal.pbio.0060001.g003
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in the movement during phase III (unpublished data). Thus,
in this respect, the pan1Dacidic mutation suppressed the
phenotype of the las17Dacidic mutation, suggesting that Pan1
and Las17 have opposing actions on Arp2/3 complex in this
later phase of patch lifetime.
Abp1 Has a Role in the Early Phases of Patch Dynamics
Abp1 is present at the patch just before movement of the
patch away from the membrane to the end of its life. Abp1
has two acidic/DDW regions that bind the Arp2/3 complex
(Figure 1A) and an ADFH domain that binds F-actin [44]. In
early studies, abp1D null mutants were nearly normal in many
respects, but the abp1D mutation has been found to have
genetic interactions with sla1D, sla2, and las17D mutations
[45]. Actin patches of abp1D mutants, labeled with Sla1-GFP,
showed an increase in the distance that Sla1-GFP moved from
the membrane and an increase in Sla1 and Sac6 lifetimes [23].
We found that Sla2-GFP patches of abp1D cells remained
longer at their origin (Figure 5C; p ¼ 0.0002), and the
percentage of patches that left their origin was normal
(Figure 5B). By isolating the data for patch movement away
from the membrane in phase II, we found that initial
movement of patches away from the membrane was normal
(Figure 5D, left) and that, remarkably, the ﬁnal extent of
movement was greatly increased (Figure 5D, right). Consistent
with these observations, MSD analysis of the complete tracks
showed an increase in the median lifetime of the patches and
greater movement away from the origin (Figure 5A). One
explanation for the increase in median lifetime and move-
ment is that Sla2-GFP remains on the patch for a longer time
in the absence of Abp1.
Phase III of actin patch movement in abp1D cells was
examined using Cap1-GFP as a marker; the behavior of Cap1-
GFP patches essentially mirrors that of Abp1-GFP patches in
wild-type cells [23,33]. The time that patches spent at their
origin was increased (Figure 5G), and the percentage of
patches moving away from the membrane was normal (Figure
5F, p¼ 0.08), as seen with Sla2-GFP labeling above. MSD plots
of the complete lifetime were decreased in abp1D cells, for
curves aligned at the start of their lifetime, but not at the end
(Figure 5E). We isolated the data for patch movement beyond
200 nm, and the results for abp1D cells were identical to those
for wild-type cells (Figure 5H). The Cap1-GFP results indicate
a delay in the initiation of patch movement with normal
movement after leaving the membrane for the abp1D mutant.
Considering all the data, for Sla2-GFP and Cap1-GFP
labeled patches, Abp1 appears to be important to promote
patch assembly before leaving the membrane, but not for
patch movement after leaving the membrane. In addition,
Abp1 appears to play a role in the removal of Sla1 and Sla2
from the patch after the initial movement into the cytoplasm.
Coronin as an Inhibitor of Actin Assembly
Coronin/Crn1 has been shown in vitro to inhibit the
activity of the Arp2/3 complex for nucleation of actin
polymerization [21]. To determine if coronin has such a role
in actin patch dynamics, we examined crn1D null mutant cells.
Phases I and II of patch motility, examined with Sla2-GFP,
were nearly normal in most respects, with only a slight
decrease in the MSD plot, a slight increase in median lifetime
(Figure 6A, left), and a slight increase in time at the origin
(Figure 6C; p¼0.001). With Abp1-GFP labeling of patches, the
time spent at the origin was increased but not the probability
of leaving the origin (Figure 6F and 6G), similar to the results
with Sla2-GFP. Together, these results suggest a minor delay
in the transition from phase I to II when coronin is absent,
suggesting that coronin promotes the ability of patches to
move off the membrane.
Phase III dynamics in crn1D mutant cells, examined using
Abp1-GFP, showed a rightward shift in the MSD plot with
Figure 4. Quantitative Analysis of Actin Patch Motility in Cells Lacking the Arp2/3-Binding Regions of Pan1 and WASp/Las17
Cells express Sla2-GFP (A–C) or Abp1-GFP (D–F). (A and D) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their
lifetimes. The curves on the left are truncated at the median lifetime. (B and E) Percentage of patches that leave the origin. Mean of values for three
segregants is shown. (C and F) Average time at the origin, from the appearance of a patch until it moved away or disappeared.
Strain numbers and numbers of patches: (A–C) Wild-type, YJC5707 - 9; 66, 84, and 69. las17Dacidic, YJC5713–5; 100, 95, and 104. pan1Dacidic, YJC5710–
2; 103, 76, and 74. las17Dacidic pan1Dacidic, YJC5716–8; 100, 86, and 91. (D–F) Wild-type, YJC5719–22; 99, 100, 114, and 98. las17Dacidic, YJC5726, 8 & 9;
95, 88, and 84. pan1Dacidic, YJC5723–5; 102, 94, and 139. las17Dacidic pan1Dacidic, YJC5730–3; 77, 70, 50, and 50. Error bars are 6 standard error.
doi:10.1371/journal.pbio.0060001.g004
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curves aligned at the start for the mutant (Figure 6E, left). The
plot extended to greater distances and longer times, suggest-
ing that patches moved farther and longer in the absence of
coronin. In support of this idea, when the curves were aligned
at the end of patch lifetime, the MSD plot showed increased
movement of crn1D patches (Figure 6E, right). Isolating the
data for movement of Abp1-GFP patches in phase III, crn1D
patches showed more movement by MSD analysis, with curves
aligned at the start or end of their lifetime (Figure 6H). Thus,
coronin appears to inhibit the movement of patches after
they move away from the membrane and into the cytoplasm.
Discussion
Cells have a number of proteins with the biochemical
ability to regulate the Arp2/3 complex. Whether these
proteins have such roles in cells and, if so, how those roles
are manifested and coordinated are important questions in
understanding the cell biology of actin assembly and motility.
Our results demonstrate that the collection of Arp2/3
regulatory proteins in yeast have largely distinct functions
in generating actin assembly to create force and movement
during endocytosis. In some situations, individual functions
can overlap, increasing the robustness of the system. Figure 7
summarizes the results, illustrating the roles of speciﬁc
regulators in the stereotyped series of processes that compose
the assembly and movement of cortical actin patches as part
of endocytosis.
Assembly of the Actin Patch
Early in the life of an actin patch, a series of proteins are
recruited to a location on the plasma membrane, assembling
the machinery required for endocytosis [24]. During this time,
the actin patch appears to be tethered or corralled, under-
going random movements conﬁned to a small area [24,33].
Assembly of a dendritic network of actin ﬁlaments proceeds
[24,33], which appears to be needed for the movement of the
actin patch and endocytic vesicle away from the membrane.
Our results show that, on some level, essentially all of the
Arp2/3 regulatory proteins play a role in these initial phases
of the process. Mutations in these proteins alter the amount
of time that patches persist at the site of their appearance,
undergoing tethered movement, which is termed phase I. For
the WASp Las17 and the EH domain protein Pan1, mutations
Figure 5. Quantitative Motion Analysis of Actin Patches in Null Mutants Lacking Abp1
Cells express Sla2-GFP (A–D) or Cap1-GFP (E–H). (A and E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their
lifetimes. The curves on the left are truncated at the median lifetime. (B and F) Percentage of patches that leave the origin. Mean of values for three
segregants is shown. (C and G) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement
only. For each patch, data prior to movement were removed. Only patches that moved away from the origin were included. (H) Phase III movement
only. For each patch, data prior to the time the patch traveled 200 nm were removed. Only patches that moved more than 200 nm from the origin were
included.
Strain numbers and number of patches: (A–C) Wild-type, YJC5457–9; 157, 141, and 151. abp1D, YJC5454–6; 95, 118, and 85. (D) Strains as in (A–C).
Numbers of patches: wild-type – 153, 135, 135. abp1D – 92, 112, 84. (E–G) Wild-type, YJC5681–3; 74, 75, and 72. abp1D, YJC5684–6; 62, 58, and 57. (H)
Strains as in (E–G). Numbers of patches: wild-type – 64, 69, 64. abp1D – 44, 43, 51 Error bars are 6 standard error.
doi:10.1371/journal.pbio.0060001.g005
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of the Arp2/3-binding region prolonged the duration of
phase I, as did null mutations for the type-I myosin Myo5,
coronin, and Abp1. Mutations in the Arp2/3-binding motif of
Las17 delays the appearance of Abp1-GFP at patches,
suggesting that although the other Arp2/3 activators can
eventually assemble an actin ﬁlament network, they do so less
efﬁciently without Las17.
Combinations of Arp2/3-binding mutations reveal the
potential for overlapping function among the regulators.
For example, combining the las17Dacidic mutation with the
pan1Dacidic, the myo5Dacidic, or the myo5Dacidic myo3Dacidic
mutations further prolonged the time for patch assembly in
phase I. Arp2/3 regulators are likely required at this stage to
ensue the proper targeting and activity level of the Arp2/3
complex to generate a functional actin network for move-
ment. In their absence, the network may not have the proper
branch density and ﬁlament length required to initiate
invagination and/or movement.
Patch Movement away from the Plasma Membrane: WASp
and Type-I Myosin
The ﬁrst nonrandom movement of an actin patch is a short
one away from the plasma membrane into the cytoplasm,
which has been hypothesized to represent membrane
invagination to form an endocytic cup [24]. Complete
deletions of the type-I myosin genes had the greatest effect
on this movement. Loss of Myo5 decreased the probability
that a patch would undergo phase II movement, and it
lessened the extent of movement per se. Loss of both Myo3
and Myo5 resulted in almost no movement away from the
cortex, supporting a model that type-I myosins are needed to
power this movement prior to vesicle scission [15].
Given the severity of the phenotypes in the type-I myosin
null mutants, we were surprised to ﬁnd that truncation of the
type-I myosin Arp2/3-binding regions had little or no effect.
Myo3 and Myo5 have been suggested to function in
coordination with or in parallel with WASp/Las17, perhaps
as a multisubunit complex [14,17,42]. When we combined
Arp2/3-binding mutations of WASp/Las17 with those of type-I
myosins, the phenotype was enhanced, consistent with that
view. In las17Dacidic myo5Dacidic and las17Dacidic myo3Dacidic
myo5Dacidic cells, actin patches failed to move away from the
origin. Verprolin/Vrp1, the yeast homologue of WIP was
suggested to function as a scaffold or central component of
such a multisubunit complex [14]. In support of that view, loss
of Vrp1 caused a complete loss of actin patch movement [15].
Figure 6. Quantitative Motion Analysis of Actin Patches in Null Mutants Lacking Coronin, Crn1
Cells express Sla2-GFP (A–D) or Abp1-GFP (E–H). (A and E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their
lifetimes. The curves on the left are truncated at the median lifetime. (B and F) Percentage of patches that leave the origin. Mean of values for three
segregants. (C and G) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For
each patch, data prior to movement were removed. Only patches that moved away from the origin were included. (H) Phase III movement only. For
each patch, data prior to the time the patch traveled 200 nm were removed. Only patches that moved more than 200 nm from the origin were included.
Strain numbers and number of patches: (A–C) Wild-type, YJC5449 - 51; 177, 192, 173. crn1D, YJC5446–8; 155, 202, 147. (D) Strains as in (A–C). Numbers
of patches: wild-type – 165, 182, 152. crn1D – 143, 184, 142. (E–G) Wild-type, YJC4297–9; 74, 62, 57. crn1D, YJC4235, 6 & 9; 88, 74, 72. (H) Strains as in (E–
G). Numbers of patches: wild-type – 67, 59, 49. crn1D – 84, 68, 69 Error bars are 6 standard error.
doi:10.1371/journal.pbio.0060001.g006
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In our hands, the loss of Vrp1 caused an almost complete loss
of inward movement in plots of MSD (unpublished data).
Many Arp2/3 regulators are dispensable for phase II
movement. Deletion of the acidic domain of Las17 or Pan1,
independently or together, had no effect. The loss of neither
coronin nor Abp1 affected this movement. Loss of Abp1 did
result in Sla2-GFP–labeled patches moving farther away from
the cortex than normal, which supports the view that Abp1
may help to remove early components such as Sla1 and Sla2
from the patch [23].
Phase II may not depend on precise regulation of Arp2/3
localization or activation, because no single Arp2/3 binding
mutant had a detrimental effect on this movement. However,
previous studies of the capping protein suggest that the
regulation of the number of free barbed ends is critical for
normal movement during phase II. Furthermore, in the
absence of the Arp2/3-binding regions of Las17/WASp and
the type-I myosins, phase II movement fails to occur. This
failure in phase II may reﬂect a requirement for Arp2/3
activation during phase II movement itself or it may also
reﬂect a failure to establish a proper network during the
phase I. In addition, the motor activities of the type-I myosins
appear to play some role in the in initial movement of
patches away from the membrane [15].
Patch Movement in the Cytoplasm
After the actin patch departs the plasma membrane, it
moves faster and farther, through the cytoplasm. When the
Arp2/3-binding region of WASp/Las17 was truncated, actin
patches had a severe defect in phase III movement, which is
important in light of the relative normalcy of phase II
movement for this mutant. The simplest interpretation of
these results is that WASp/Las17 remains bound to the
endocytic vesicle as it moves through the cytoplasm,
analogous to the situation for the movement of pathogens
in cells or beads in cell extracts.
GFP-WASp fusions at the N and C termini were not seen to
leave the membrane in this manner in previous studies in
budding and ﬁssion yeast, including some in our lab
[24,33,35]. We observed that tagging WASP/Las17 at either
end with GFP results in defects in actin patch motility
reminiscent of those seen in las17Dacidic strains (Figures S2–
S4). We also observed that overexpressed Las17, tagged at the
N terminus, did leave the membrane and move about the
cytoplasm, in the manner of actin patches and endocytic
vesicles (Figure 2I–2J). To be fair, the ﬂuorescence of these
foci of GFP-Las17 was weak, and Abp1-tdimer2 patch
movement in these cells was defective. Therefore, it remains
a possibility that Las17 may not normally leave the membrane
with patches.
Our results with coronin address this question of how the
patch moves through the cytoplasm. The coronin null mutant
showed increased patch movement during phase III, which is
consistent with the prediction from biochemical studies that
coronin inhibits the activity of Arp2/3 complex. Yeast Arp2/3
complex is highly active in the absence of any activator when
actin from yeast is used [11], so an inhibitor, namely coronin,
may be quite important in this system. The loss of the capping
Figure 7. A Model for Endocytosis and Actin Patch Assembly, with a Summary of the Requirements for Individual Arp2/3 Regulatory Proteins
During phase I, almost all of the Arp2/3 regulators have a role in promoting assembly. At this stage, Arp2/3 regulators presumably act to establish a
proper actin network with appropriate filament lengths and branch density. During phase II, Arp2/3 regulation is complex. Mutation of no single Arp2/3
regulator affected this stage, but simultaneous mutation of the Arp2/3 binding regions of WASp/Las17, Myo3, and Myo5 did disrupt this movement.
Capping protein also has a role at this stage [33]. During phase III, several lines of evidence support a model where actin filaments, nucleated at the
actin patch, drive movement of the vesicle through the cytoplasm. In this model, barbed ends are oriented toward the vesicle (see Discussion).
doi:10.1371/journal.pbio.0060001.g007
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protein resulted in a speciﬁc defect of phase III movement
[33], which is also consistent with the model. Together, these
results with WASp/Las17, coronin, and capping protein
provide evidence that Arp2/3-mediated actin assembly
powers the movements of phase III, which supports the
relevance of the dendritic nucleation model for this process.
Several key components of the dendritic nucleation model
are known to be present on patches during phase III
movement, including actin, the Arp2/3 complex, capping
protein, and now WASp/Las17 [23,24,30,33].
The location of actin ﬁlament nucleation and the orienta-
tion of the actin ﬁlaments during actin patch assembly and
movement is an important question. When endocytosis is
blocked in sla2D cells, actin ‘‘comet tails’’ appear at the
plasma membrane, with growing barbed ends oriented
toward the membrane [24]. However, it is unclear where
actin ﬁlaments are nucleated when endocytosis is proceeding
normally, especially during invagination and during move-
ment after the patch leaves the plasma membrane. No actin
connection between the plasma membrane and a phase II or
III patch can be seen. If ﬁlaments growing at the plasma
membrane were responsible for this movement, the newest
parts of the network would be at the membrane, and would
likely be relatively bright when monitored by ﬂuorescent
fusion proteins. This is not the case. Previous results show
that actin cables do not drive patch movement in the
cytoplasm [33]. We therefore favor a model where actin
ﬁlaments are being nucleated at the surface of the endocytic
vesicle, during and after invagination.
We observed some longer-lived GFP-Las17–labeled par-
ticles moving in the interior of the cell without ﬁrst seeing
them leave the plasma membrane. For actin patches, this type
of observation was very rare. Whether these GFP-Las17
particles represent a later stage of actin patches, endocytic
vesicles, or another cellular compartment remains to be
determined. The character of the movement of these
particles is reminiscent of what has been seen by studying
the membrane receptor Ste2 or the lipid dye FM4–64, which
follow endocytic trafﬁcking pathways [33,36]. In previous
studies, the movement of Ste2-GFP particles was impaired
when WASp/Las17 was truncated or when Lsb6, a Las17-
binding protein, was absent [36,37], which also supports the
hypothesis that Las17 is needed to drive Ste2 vesicles.
Materials and Methods
Yeast strains. The strains used in this study are listed in Table S1
and their construction is described in Protocol S1.
Microscopy. For each genotype, two or three mutant and wild-type
haploid segregants from a heterozygous diploid were tested. For each
segregant, movies were collected from eight different cells. Strains
were grown overnight in YPD at 25 8C or 30 8C to an optical density at
600 nm (OD600) of 0.1–0.5. Cells were harvested by centrifugation at
82g, suspended in SD-complete media, placed on 2% agarose pads
made with SD-complete, and covered with a number 1 coverslip as
described [33]. GFP ﬂuorescence movies were made using a spinning-
disc confocal microscope system consisting of an upright microscope
(BX52, Olympus) with a PlanApo100X 1.4 NA oil immersion
objective, a CSU10 Yokogawa spinning disc head (Solomere
Technology), and an intensiﬁed charge coupled device (CCD) video
camera (XR Mega10 S30 camera, Stanford Photonics). Two color
images were collected sequentially using a LMM5 Laser Merge
Module (Spectral Applied Research), a multipass dichroic mirror,
and emission ﬁlters in a Lambda 10–3 high-speed ﬁlter wheel (Sutter
Instruments). The temperature was maintained at 30 8C. Large
budded cells were selected for observation. Images were collected
from a single focal plane at the equator of the cell. Abp1-GFP, Abp1-
tdimer2, Sla2-GFP, and GFP-Las17 movies were collected at frame
rates of 5/s, 5/s, 2/s, and 2/s, respectively. For quantitative motion
analysis, 200 consecutive frames were collected. Images were
collected using QED In Vivo software (Media Cybernetics), except
for the experiments in Figure 4D–4F and Figure 2I–2K, which were
collected using Piper Imaging.
Computer-assisted patch tracking and quantitative motion analy-
sis. GFP-labeled actin patches in movies were tracked using
previously described software [31]. The experimenter veriﬁed every
patch track using an ImageJ (National Institutes of Health) plug-in
that overlaid the position information from the tracking software
onto the original movie, and necessary corrections were made by
hand. The data were then imported into an Excel spreadsheet
(Microsoft). Tracks were retained for analysis if they met the
following criteria: (1) The patch was observed for at least 30 frames
(6 s for Abp1-GFP and 15 s for Sla2-GFP). (2) The patch originated
near the cortex. (3) The patch disappeared during the movie. (4) The
patch was readily distinguished from other patches. These criteria
enrich our sample for patches whose entire lifetime is captured in the
movie. Zero time for a track was deﬁned as the time at which the
patch was ﬁrst observed, and the end point was deﬁned as the last
time point at which the patch was observed.
The character and extent of the motion of GFP-labeled patches
was analyzed ﬁrst with plots of MSD versus time. To calculate MSD,
the square of the distance of each patch from its origin was calculated
at each time point. The squared displacement values were averaged
for all the patches from all the cells of each segregant of a particular
genotype. The degree of variation among individual tracks was high,
as seen in previous studies, so we averaged the data for 150 to 542
patches for each genotype. To test for statistical signiﬁcance, MSD
curves from each segregant of one genotype were ﬁrst compared by
analysis of variance (ANOVA) to ensure that they yielded the same
result. A grand MSD versus time plot was then generated, averaging
the data for all of the patches from all of the segregants of a given
genotype within one experiment. Before averaging, the squared
displacement values for each patch were aligned at the beginning or
end of the track lifetime. Examples of how a set of data was aligned in
the two ways before averaging are shown in Figure 1C. Plots aligned
‘‘at the start’’ or ‘‘on the left’’ provide information about the behavior
of patches in the early part of their life. These curves are truncated at
the time when 50% of the patches have disappeared, representing the
median lifetime. Plots aligned ‘‘at the end’’ or ‘‘on the right’’ allow for
a better understanding of the motion of GFP-labeled actin patches
later in their lifetime, away from the origin. Comparisons between
genotypes were evaluated using Student’s t-test.
The patch tracking data were analyzed in additional ways. For
individual patch track data of X-Y position and time, we determined
if a patch left its origin and how long it remained at its origin before
it moved away or disappeared. To analyze ‘‘phase II only’’ data after
initiation of movement, the data for Sla2-GFP patches after they
moved away from the origin were selected. MSD versus time plots
were generated with these data. To analyze ‘‘phase III only,’’ we
selected the data for Abp1-GFP labeled patches after they moved
more than 200 nm away from the origin. MSD plots were generated.
Supporting Information
Figure S1. Histogram of the Time between Sla2-GFP and Abp1-
tdimer2 Recruitment to Actin Patches
All strains express Sla2-GFP and Abp1-tdimer2. The median time for
Abp1-tdimer2 recruitment þ/- presented. Strain numbers and the
number of patches were as follows: wild-type, YJC6044, 6046; 212 and
126, respectively. las17Dacidic, YJC6041, 6043; 132 and 131 respec-
tively.
Found at doi:10.1371/journal.pbio.0060001.sg001 (536 KB AI).
Figure S2. Quantitative Motion Analysis of Abp1-tdimer2 Patches in
Wild-Type and las17-GFP Cells
All cells express Abp1-tdimer2, and the movement of Abp1-tdimer2
was analyzed. Experiments were done using a different ﬂuorophore
to mark Abp1, and data were collected on a different microscope, so
MSD values do not match those in other ﬁgures. (A) MSD plots for
patches aligned at the start (left) or end (right) of their lifetimes. The
curves on the left are truncated at the median lifetime.
(B) Percentage of patches that leave the origin. Mean of values for
three segregants is shown.
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(C) Average time at the origin, from the appearance of a patch until it
moved away or disappeared.
(D) Phase III movement only. For each patch, data prior to the time
the patch traveled 200 nm were removed. Only patches that moved at
least 200 nm are included. Strain numbers and the number of patches
were as follows: wild-type, YJC5950–2; 59, 79, and 69, respectively.
las17-GFP, YJC5953–5; 87, 83, and 85. (D) Strains as in (A–C). Numbers
of patches: wild-type – 57, 75, 66. las17-GFP – 81, 69, 76. Error bars are
6 standard error.
Found at doi:10.1371/journal.pbio.0060001.sg002 (412 KB AI).
Figure S3. Quantitative Motion Analysis of Abp1-tdimer2 Patches in
Wild-Type and GFP-las17 Cells
GFP-Las17 is expressed under the control of the endogenous
promoter at the locus. All cells express Abp1-tdimer2, and the
movement of Abp1-tdimer2 was analyzed.
(A) MSD plots for patches aligned at the start (left) or end (right) of
their lifetimes. The curves on the left are truncated at the median
lifetime.
(B) Percentage of patches that leave the origin. Mean of values for
three segregants is shown.
(C) Average time at the origin, from the appearance of a patch until it
moved away or disappeared.
(D) Phase III movement only. For each patch, data prior to the time
the patch traveled 200 nm were removed. Only patches that moved at
least 200 nm are included. Strain numbers and the number of patches
were as follows: wild-type, YJC6180–2; 112, 104, and 110, respectively.
GFP-las17, YJC6183–5; 126, 108, and 92. (D) Strains as in (A–C).
Numbers of patches: wild-type – 106, 95, 104. las17-GFP – 116, 90, 77.
Error bars are 6 standard error.
Found at doi:10.1371/journal.pbio.0060001.sg003 (425 KB AI).
Figure S4. Quantitative Motion Analysis of Abp1-tdimer2 Patches in
Wild-Type and GAL1-GFP-las17 Cells
All cells were grown in the presence of galactose as the sole carbon
source and express Abp1-tdimer2. The movement of Abp1-tdimer2
was analyzed.
(A) MSD plots for patches aligned at the start (left) or end (right) of
their lifetimes. The curves on the left are truncated at the median
lifetime.
(B) Percentage of patches that leave the origin. Mean of values for
three segregants is shown.
(C) Average time at the origin, from the appearance of a patch until it
moved away or disappeared.
(D) Phase III movement only. For each patch, data prior to the time
the patch traveled 200 nm were removed. Only patches that moved at
least 200 nm are included. Strain numbers and the number of patches
were as follows: wild-type, YJC6023–4; 37, 70, and 47, respectively.
GAL1-GFP-las17, YJC6021–2; 66 and 66. (D) Strains as in (A–C).
Numbers of patches: wild-type – 29, 65, 41. GAL1-GFP-las17 – 50, 46.
Error bars are 6 standard error.
Found at doi:10.1371/journal.pbio.0060001.sg004 (419 KB AI).
Protocol S1. Description of the Generation of Strains Used
Found at doi:10.1371/journal.pbio.0060001.sd001 (55 KB DOC).
Table S1. Strains Used in This Study
Found at doi:10.1371/journal.pbio.0060001.st001 (281 KB DOC).
Video S1. Sla2-GFP in Wild-Type Strain YJC5457
10X speed. Video speed 20 frames/s. Data collected at 2 frames/s.
Found at doi:10.1371/journal.pbio.0060001.sv001 (9.8 MB MOV).
Video S2. Abp1-GFP in Wild-Type Strain YJC4816
4X speed. Video speed 20 frames/s. Data collected at 5 frames/s.
Found at doi:10.1371/journal.pbio.0060001.sv002 (9.1 MB MOV).
Video S3. GFP-Las17 in Strain YJC5736
Includes examples of GFP-Las17, expressed under control of the
GAL1 promoter, moving away from the membrane. 10X speed. Video
speed 20 frames/s. Data collected at 2 frames/s.
Found at doi:10.1371/journal.pbio.0060001.sv003 (3.3 MB MOV).
Video S4. GFP-Las17 in Strain YJC5737
Includes examples of GFP-Las17, expressed under control of the
GAL1 promoter, moving away from the membrane. 10X speed. Video
speed 20 frames/s. Data collected at 2 frames/s.
Found at doi:10.1371/journal.pbio.0060001.sv004 (7.3 MB MOV).
Video S5. GFP-Las17 (Green) and Abp1-tdimer2 in Strain YJC6179
Includes an example of GFP-Las17, expressed under control of the
GAL1 promoter, moving off the membrane with Abp1-tdimer2
(arrowhead). 2.5X speed. Video speed 5 frames/s. Data collected at 1
frame every 2 s. Red and green channels were collected sequentially at
1-s intervals.
Found at doi:10.1371/journal.pbio.0060001.sv005 (310 KB MOV).
Video S6. GFP-Las17 in Strain YJC5737, Expressed under Control of
the GAL1 Promoter
Includes examples of long-lived particles moving in the cytoplasm
that do not originate at the membrane (arrowheads). 10X speed.
Video speed 20 frames/s. Data collected at 2 frames/s.
Found at doi:10.1371/journal.pbio.0060001.sv006 (3.5 MB MOV).
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